AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (September 16, 2004). doi:10.1152/ajpgi.00227.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/2/G327    most recent
00227.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mottino, A. D.
Right arrow Articles by Vore, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mottino, A. D.
Right arrow Articles by Vore, M.
Submitted on May 18, 2004
Accepted on September 8, 2004

ROLE OF MICROTUBULES IN ESTRADIOL-17{beta}-D-GLUCURONIDE-INDUCED ALTERATION OF CANALICULAR MRP2 LOCALIZATION AND ACTIVITY

Aldo D. Mottino1, Fernando A. Crocenzi2, Enrique J. Sanchez Pozzi2, Luis M. Veggi2, Marcelo G. Roma2, and Mary Vore3*

1 Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky, USA; Institute of Experimental Physiology, National University of Rosario, Argentina
2 Institute of Experimental Physiology, National University of Rosario, Argentina
3 Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky, USA

* To whom correspondence should be addressed. E-mail: maryv{at}pop.uky.edu.

Estradiol-17{beta}-D-glucuronide (E2-17G) induces a marked but reversible inhibition of bile flow in the rat together with endocytic retrieval of Mrp2 from the canalicular membrane to intracellular structures. We analyzed the effect of pretreatment (100 min) with the microtubule inhibitor, colchicine, or lumicholchicine, its inactive isomer (1 µmol/kg, i.v.), on changes in bile flow and localization and function of Mrp2 induced by E2-17G (15 µmol/kg, i.v.). Bile flow and biliary excretion of bilirubin, an endogenous Mrp2 substrate, were measured throughout, while Mrp2 localization was examined at 20 and 120 min after E2-17G by confocal immunofluorescence microscopy and Western analysis. Colchicine pretreatment alone did not affect bile flow or Mrp2 localization and activity over the short time scale examined (3-4 hr). Administration of E2-17G to colchicine-pretreated rats induced a marked decrease (85%) in bile flow and biliary excretion of bilirubin as well as internalization of Mrp2 at 20 min. These alterations were of a similar magnitude as in rats pretreated with lumicolchicine followed by E2-17G. Bile flow and Mrp2 localization and activity were restored to control levels within 120 minutes of E2-17G in animals pretreated with lumicolchicine. In contrast, in colchicine-pretreated rats followed by E2-17G, bile flow and Mrp2 activity remained significantly inhibited by 60%, and confocal and Western studies revealed sustained internalization of Mrp2 120 min after E2-17G. We conclude that recovery from E2-17G cholestasis, associated with exocytic insertion of Mrp2 in the canalicular membrane, but not its initial E2-17G-induced endocytosis, is a microtubule-dependent process.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.